DK3015467T3 - Morpholino-oligonukleotidfremstillingsfremgangsmåde - Google Patents
Morpholino-oligonukleotidfremstillingsfremgangsmåde Download PDFInfo
- Publication number
- DK3015467T3 DK3015467T3 DK14800406.2T DK14800406T DK3015467T3 DK 3015467 T3 DK3015467 T3 DK 3015467T3 DK 14800406 T DK14800406 T DK 14800406T DK 3015467 T3 DK3015467 T3 DK 3015467T3
- Authority
- DK
- Denmark
- Prior art keywords
- morpholino
- preparation process
- oligonucleotide preparation
- oligonucleotide
- preparation
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/111—General methods applicable to biologically active non-coding nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/323—Chemical structure of the sugar modified ring structure
- C12N2310/3233—Morpholino-type ring
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2330/00—Production
- C12N2330/30—Production chemically synthesised
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013110358 | 2013-05-24 | ||
| PCT/JP2014/063750 WO2014189142A1 (ja) | 2013-05-24 | 2014-05-23 | モルフォリノオリゴヌクレオチドの製造方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3015467T3 true DK3015467T3 (da) | 2025-02-10 |
Family
ID=51933692
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK14800406.2T DK3015467T3 (da) | 2013-05-24 | 2014-05-23 | Morpholino-oligonukleotidfremstillingsfremgangsmåde |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US9790497B2 (da) |
| EP (1) | EP3015467B1 (da) |
| JP (1) | JP6477464B2 (da) |
| CN (1) | CN105228999B (da) |
| DK (1) | DK3015467T3 (da) |
| WO (1) | WO2014189142A1 (da) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2370451B1 (en) | 2008-12-02 | 2016-11-16 | Wave Life Sciences Japan, Inc. | Method for the synthesis of phosphorus atom modified nucleic acids |
| BR112012000828A8 (pt) | 2009-07-06 | 2017-10-10 | Ontorii Inc | Novas pró-drogas de ácido nucleico e métodos de uso das mesmas |
| US10428019B2 (en) | 2010-09-24 | 2019-10-01 | Wave Life Sciences Ltd. | Chiral auxiliaries |
| BR112014001244A2 (pt) | 2011-07-19 | 2017-02-21 | Wave Life Sciences Pte Ltd | métodos para a síntese de ácidos nucléicos funcionalizados |
| JP6268157B2 (ja) | 2012-07-13 | 2018-01-24 | 株式会社Wave Life Sciences Japan | 不斉補助基 |
| KR20240148947A (ko) | 2012-07-13 | 2024-10-11 | 웨이브 라이프 사이언시스 리미티드 | 키랄 제어 |
| EP3095459A4 (en) | 2014-01-15 | 2017-08-23 | Shin Nippon Biomedical Laboratories, Ltd. | Chiral nucleic acid adjuvant having antitumor effect and antitumor agent |
| EP3095461A4 (en) | 2014-01-15 | 2017-08-23 | Shin Nippon Biomedical Laboratories, Ltd. | Chiral nucleic acid adjuvant having immunity induction activity, and immunity induction activator |
| CN106068325B (zh) | 2014-01-16 | 2021-07-09 | 波涛生命科学有限公司 | 手性设计 |
| JP6673211B2 (ja) * | 2014-10-14 | 2020-03-25 | 味の素株式会社 | モルフォリノオリゴヌクレオチドの製造方法 |
| EP4049991A1 (en) | 2015-01-21 | 2022-08-31 | Ajinomoto Co., Inc. | Precipitation promoter and precipitation method in which same is used |
| MA45362A (fr) | 2016-05-24 | 2019-04-10 | Sarepta Therapeutics Inc | Procédés de préparation d'oligomères morpholino de phosphorodiamidate |
| MX390906B (es) | 2016-05-24 | 2025-03-21 | Sarepta Therapeutics Inc | Procesos para preparar oligómeros de morfolino fosforodiamidato. |
| AU2017270598B2 (en) * | 2016-05-24 | 2022-12-01 | Sarepta Therapeutics, Inc. | Processes for preparing phosphorodiamidate morpholino oligomers |
| EP3464305B1 (en) * | 2016-05-24 | 2024-08-21 | Sarepta Therapeutics, Inc. | Processes for preparing oligomers |
| MA45155B1 (fr) | 2016-05-24 | 2024-06-28 | Sarepta Therapeutics, Inc. | Procédés de préparation d'oligomères morpholino de phosphorodiamidate |
| US11472824B2 (en) | 2016-05-24 | 2022-10-18 | Sarepta Therapeutics, Inc. | Processes for preparing phosphorodiamidate morpholino oligomers |
| WO2018057430A1 (en) | 2016-09-20 | 2018-03-29 | The Regents Of The University Of Colorado, A Body Corporate | Synthesis of backbone modified morpholino oligonucleotides and chimeras using phosphoramidite chemistry |
| TWI812647B (zh) * | 2017-09-25 | 2023-08-21 | 美商薩羅塔治療公司 | 經由速流合成以製備磷醯二胺嗎啉代寡聚物之製程 |
| WO2019216433A1 (ja) | 2018-05-10 | 2019-11-14 | 日本新薬株式会社 | オリゴ核酸化合物の製造方法 |
| PE20210630A1 (es) * | 2018-06-26 | 2021-03-23 | Nippon Shinyaku Co Ltd | Composicion que comprende el oligonucleotido antisentido y su uso para el tratamiento de la distrofia muscular de duchenne |
| WO2021095875A1 (ja) | 2019-11-13 | 2021-05-20 | 日本新薬株式会社 | オリゴ核酸化合物の製造方法 |
| WO2021095874A1 (ja) | 2019-11-13 | 2021-05-20 | 日本新薬株式会社 | オリゴ核酸化合物の製造方法 |
| JP7703579B2 (ja) * | 2020-07-10 | 2025-07-07 | チャンヂョウ シンザオール ファーマシューティカルズ カンパニー リミテッド | オリゴヌクレオチドを調製するための方法 |
| CA3218264A1 (en) * | 2021-04-28 | 2022-11-03 | Nippon Shinyaku Co., Ltd. | Method for producing oligonucleic acid compound |
| US12378267B2 (en) | 2021-06-17 | 2025-08-05 | Entrada Therapeutics, Inc. | Synthesis of FMOC-protected morpholino monomers and oligomers |
| JP7220439B1 (ja) | 2022-03-14 | 2023-02-10 | 国立大学法人東北大学 | キメラ分子の製造方法 |
| CA3249036A1 (en) | 2022-04-22 | 2023-10-26 | Entrada Therapeutics Inc | CYCLIC PEPTIDES FOR ADMINISTERING THERAPEUTIC AGENTS |
| WO2024083746A1 (en) | 2022-10-17 | 2024-04-25 | Bachem Holding Ag | Method and composition for oligonucleotide synthesis |
| CN116283418B (zh) * | 2023-05-25 | 2023-08-11 | 地康食安(北京)农业科技有限公司 | 一种固载微生物的植物生长促进剂及其制备方法 |
| WO2025082632A1 (en) | 2023-10-16 | 2025-04-24 | Bachem Holding Ag | Method and composition for oligonucleotide synthesis |
| WO2025085868A2 (en) | 2023-10-20 | 2025-04-24 | Radiation Control Technologies, Inc. | Cd47-targeting morpholinos |
| WO2025151707A1 (en) * | 2024-01-11 | 2025-07-17 | Entrada Therapeutics, Inc. | Method for preparing multimers of phosphorodiamidate morpholino oligomers |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5521063A (en) | 1985-03-15 | 1996-05-28 | Antivirals Inc. | Polynucleotide reagent containing chiral subunits and methods of use |
| US5185444A (en) | 1985-03-15 | 1993-02-09 | Anti-Gene Deveopment Group | Uncharged morpolino-based polymers having phosphorous containing chiral intersubunit linkages |
| US5506337A (en) | 1985-03-15 | 1996-04-09 | Antivirals Inc. | Morpholino-subunit combinatorial library and method |
| JPH01172384A (ja) * | 1987-12-25 | 1989-07-07 | Ajinomoto Co Inc | 新規ヌクレオシド誘導体およびこれを含有する抗ウィルス剤 |
| WO1991009033A1 (en) | 1989-12-20 | 1991-06-27 | Anti-Gene Development Group | Uncharged morpholino-based polymers having phosphorous-containing chiral intersubunit linkages |
| JP2000044493A (ja) | 1998-07-27 | 2000-02-15 | Asahi Chem Ind Co Ltd | 化合物ライブラリー合成用保護基 |
| JPWO2006104166A1 (ja) | 2005-03-29 | 2008-09-11 | 国立大学法人東京農工大学 | 晶析分離用担体及び化合物の分離方法 |
| US7790694B2 (en) | 2005-07-13 | 2010-09-07 | Avi Biopharma Inc. | Antisense antibacterial method and compound |
| US8067571B2 (en) | 2005-07-13 | 2011-11-29 | Avi Biopharma, Inc. | Antibacterial antisense oligonucleotide and method |
| DK1927584T3 (da) | 2005-09-20 | 2017-02-20 | Jitsubo Co Ltd | Bærer til separation, fremgangsmåde til separation af forbindelse og fremgangsmåde til syntese af peptid under anvendelse af bæreren |
| CN101405240B (zh) | 2006-03-24 | 2012-07-25 | 日商·Jitsubo株式会社 | 有机合成用试剂、以及使用该试剂的有机合成反应方法 |
| DK2207779T3 (da) * | 2007-11-15 | 2014-07-14 | Sarepta Therapeutics Inc | Fremgangsmåde til syntese af morpholinooligomerer |
| US8076476B2 (en) | 2007-11-15 | 2011-12-13 | Avi Biopharma, Inc. | Synthesis of morpholino oligomers using doubly protected guanine morpholino subunits |
| US8299206B2 (en) | 2007-11-15 | 2012-10-30 | Avi Biopharma, Inc. | Method of synthesis of morpholino oligomers |
| EP2415745A4 (en) | 2009-03-30 | 2014-06-11 | Ajinomoto Kk | DIPHENYLMETHANE COMPOUND |
| JP5548852B2 (ja) * | 2009-05-29 | 2014-07-16 | 国立大学法人東京農工大学 | 疎水性基結合ヌクレオシド、疎水性基結合ヌクレオシド溶液、及び疎水性基結合オリゴヌクレオチド合成方法 |
| CA2813183C (en) | 2010-09-30 | 2017-09-19 | Nippon Shinyaku Co., Ltd. | Morpholino nucleic acid derivatives |
| US9161948B2 (en) | 2011-05-05 | 2015-10-20 | Sarepta Therapeutics, Inc. | Peptide oligonucleotide conjugates |
| JP6478632B2 (ja) * | 2011-05-05 | 2019-03-06 | サレプタ セラピューティクス, インコーポレイテッド | ペプチドオリゴヌクレオチドコンジュゲート |
| CN103476784B (zh) | 2011-05-17 | 2017-05-24 | 味之素株式会社 | 制备寡核苷酸的方法 |
| HK1202111A1 (en) | 2011-11-18 | 2015-09-18 | Sarepta Therapeutics, Inc. | Functionally-modified oligonucleotides and subunits thereof |
| JP2013110358A (ja) | 2011-11-24 | 2013-06-06 | Nissan Motor Co Ltd | シールド筐体、及び、取付構造 |
-
2014
- 2014-05-23 JP JP2015518304A patent/JP6477464B2/ja active Active
- 2014-05-23 DK DK14800406.2T patent/DK3015467T3/da active
- 2014-05-23 WO PCT/JP2014/063750 patent/WO2014189142A1/ja not_active Ceased
- 2014-05-23 EP EP14800406.2A patent/EP3015467B1/en active Active
- 2014-05-23 CN CN201480029234.7A patent/CN105228999B/zh active Active
-
2015
- 2015-11-20 US US14/946,991 patent/US9790497B2/en active Active
-
2017
- 2017-09-14 US US15/704,467 patent/US10415036B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20180016580A1 (en) | 2018-01-18 |
| US9790497B2 (en) | 2017-10-17 |
| EP3015467A4 (en) | 2016-11-02 |
| CN105228999B (zh) | 2021-03-02 |
| EP3015467B1 (en) | 2024-12-04 |
| US10415036B2 (en) | 2019-09-17 |
| US20160076033A1 (en) | 2016-03-17 |
| EP3015467A1 (en) | 2016-05-04 |
| JPWO2014189142A1 (ja) | 2017-02-23 |
| WO2014189142A1 (ja) | 2014-11-27 |
| CN105228999A (zh) | 2016-01-06 |
| JP6477464B2 (ja) | 2019-03-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FIC20240001I1 (fi) | Tislelitsumabi | |
| NL301272I2 (nl) | Fezolinetant | |
| NL301194I2 (nl) | mosunetuzumab | |
| NL301171I1 (nl) | Tigolaner | |
| DK3015467T3 (da) | Morpholino-oligonukleotidfremstillingsfremgangsmåde | |
| DK3342773T3 (da) | Syk-hæmmere | |
| DK3613453T3 (da) | Fordamper | |
| DK3077047T3 (da) | Aramcholsalte | |
| DK3052081T3 (da) | Pastil | |
| DK3060460T3 (da) | Saddel | |
| DK3027598T3 (da) | Oxoquinazolinyl-butanamidderivater | |
| DK2956698T5 (da) | Bindestrimler | |
| FR3003883B3 (fr) | Plinthe | |
| DK2946640T3 (da) | Langmuir-probe | |
| EP2943489A4 (en) | DEUTERATED MOMELOTINIB | |
| EP2969096A4 (en) | Bottle pressurization delivery system | |
| DE102013106534B8 (de) | Chromatographiepipettenspitze | |
| EP2991647A4 (en) | DEUTERED AMLEXANOX | |
| EP2970310A4 (en) | 5-BROMO-indirubins | |
| EP2853297A4 (en) | kendama | |
| DK3071227T3 (da) | Fiskevaccine | |
| HUE050917T2 (hu) | Hidrokortizon-tartalmú készítmény | |
| HUE036203T2 (hu) | Spiro-oxazolonok | |
| DE112014001252A5 (de) | Aufbissschiene | |
| DK3086679T3 (da) | Sportssko |